+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alcohol Use Disorder Market - Global Forecast 2026-2032- Product Image
Alcohol Use Disorder Market - Global Forecast 2026-2032- Product Image
New

Alcohol Use Disorder Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5967604
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The alcohol use disorder market is experiencing accelerated transformation, driven by digital adoption, clinical advances, and evolving policy demands. Senior decision-makers must navigate shifting care models, supply chain resilience, and payer strategies to remain competitive and responsive in this dynamic landscape.

Market Snapshot: Alcohol Use Disorder Market Growth and Trends

The Alcohol Use Disorder Market expanded from USD 1.37 billion in 2025 to USD 1.46 billion in 2026 and is expected to maintain a compound annual growth rate (CAGR) of 6.78%, reaching USD 2.17 billion by 2032. This momentum is underpinned by integration of new treatment modalities, rising acceptance of technology-enabled care, and adaptive supply strategies. Leaders evaluating market positioning and operational priorities should closely assess emerging trends in digital therapeutics, clinical best practices, and payer-driven innovations as part of their strategic planning. Market participants are increasingly leveraging data-led insights and automation to streamline care delivery, foster greater adherence, and optimize reimbursement outcomes.

Scope & Segmentation of the Alcohol Use Disorder Market

  • Drug Classes: Includes acamprosate in effervescent or oral tablet form, disulfiram as oral tablets, and naltrexone available both as injectables and oral tablets; variations in formulation influence patient adherence, ease of administration, and handling protocols for different clinical environments.
  • Treatment Modalities: Covers behavioral therapy, pharmacotherapy, and combined therapy—blending cognitive behavioral therapy (CBT) or motivational enhancement therapy (MET) with medication—to address varied monitoring and operational demands.
  • End-User Settings: Encompasses home healthcare (enabled by in-person visits or telehealth), hospitals across public and private sectors, rehabilitation centers offering inpatient and outpatient programs, and specialized clinics focusing on either alcohol or psychiatric care.
  • Distribution Channels: Comprises hospital pharmacies (both public and private), online pharmacies through e-commerce or mobile platforms, retail pharmacies (including chains and independents), and specialty outlets such as Aud Specialty Pharmacies, reflecting evolving purchase and access models.
  • Formulations: Features dispersible, effervescent, injectable (including intramuscular, intravenous, subcutaneous), and oral tablet forms offered as either immediate or sustained release, with direct impact on delivery logistics and patient support mechanisms.
  • Regional Focus: Segments the market across Americas, EMEA, and Asia-Pacific regions, each with distinct regulatory frameworks, digital infrastructure levels, and payer environments; local differences in care capacity and treatment adoption significantly influence market access and operational complexity.

Key Takeaways for Senior Decision-Makers

  • Combination regimens—incorporating pharmacological, behavioral, and digital interventions—are increasingly expected as standard practice, enhancing the effectiveness and scope of treatment pathways.
  • Telehealth and digital care platforms now function as integral aspects of therapy management, supporting adherence, monitoring, and patient engagement beyond traditional in-person care.
  • Payer and regulatory dynamics are shifting toward value-based reimbursement approaches, directly impacting product pricing models, program development, and ancillary patient services.
  • Strengthening supply chain strategies, including specialized distribution for injectables and temperature-sensitive formulations, has become essential to overcoming ongoing logistical and sourcing challenges.
  • Market entry and expansion strategies must be tailored to each region, considering payer diversity, infrastructure readiness, and local clinical practices for maximum commercial impact and sustained patient access.

Tariff Impact and Procurement Shifts

Recent tariff adjustments have raised input costs for both raw materials and advanced product formats, spurring the need for greater transparency and flexibility across the supply chain. Manufacturers and distributors are proactively revising procurement methods, establishing strategic commercial partnerships, and improving inventory management to ensure uninterrupted treatment access. Care providers are adopting alternatives such as therapeutic substitution and pooled procurement approaches to manage supply risk and control expenditure. At the same time, regulatory guidance has prompted payers to reconfigure reimbursement and prior authorization workflows to preserve patient continuity and adherence within tighter budget constraints.

Methodology & Data Sources

This report blends qualitative expert interviews with systematic clinical literature review and scenario-based supply chain analysis. Insights are drawn from clinicians, pharmacists, procurement specialists, and policy leaders to ensure comprehensive coverage and cross-validated findings for every segment of the alcohol use disorder market.

Why This Report Matters

  • Facilitates the alignment of product development, supply chain management, and payer engagement to unlock both patient access and operational efficiency.
  • Delivers segment-specific insights to guide commercialization planning, channel strategies, and partnership opportunities for those seeking to enter, scale, or diversify within this market.
  • Helps senior leaders address region-specific barriers in regulatory and provider environments by providing actionable intelligence for global strategy and local execution.

Conclusion

Sustained value creation in the alcohol use disorder market hinges on aligning clinical advances, robust supply channels, and payer requirements. Evidence-driven collaboration and adaptability will define success for stakeholders navigating this evolving care ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Alcohol Use Disorder Market, by Drug Class
8.1. Acamprosate
8.1.1. Effervescent Tablet
8.1.2. Oral Tablet
8.2. Disulfiram
8.3. Naltrexone
8.3.1. Injectable
8.3.2. Oral Tablet
9. Alcohol Use Disorder Market, by Treatment Type
9.1. Behavioral Therapy
9.1.1. Cognitive Behavioral Therapy
9.1.2. Family Therapy
9.1.3. Motivational Enhancement Therapy
9.2. Combined Therapy
9.2.1. Cbt With Pharmacotherapy
9.2.2. Met With Pharmacotherapy
9.3. Pharmacotherapy
9.3.1. Injectable Drugs
9.3.2. Oral Drugs
10. Alcohol Use Disorder Market, by Formulation
10.1. Dispersible Tablet
10.2. Effervescent Tablet
10.3. Injectable
10.3.1. Intramuscular
10.3.2. Intravenous
10.3.3. Subcutaneous
10.4. Oral Tablet
10.4.1. Immediate Release
10.4.2. Sustained Release
11. Alcohol Use Disorder Market, by End User
11.1. Home Healthcare
11.1.1. Home Visits
11.1.2. Telehealth
11.2. Hospitals
11.2.1. Private Hospitals
11.2.2. Public Hospitals
11.3. Rehabilitation Centers
11.3.1. Inpatient
11.3.2. Outpatient
11.4. Specialty Clinics
11.4.1. Alcohol Rehabilitation Clinics
11.4.2. Psychiatric Clinics
12. Alcohol Use Disorder Market, by Distribution Channel
12.1. Hospital Pharmacies
12.1.1. Private Hospital Pharmacies
12.1.2. Public Hospital Pharmacies
12.2. Online Pharmacies
12.2.1. E-Commerce Websites
12.2.2. Mobile Apps
12.3. Retail Pharmacies
12.3.1. Chain Pharmacies
12.3.2. Independent Pharmacies
12.4. Specialty Pharmacies
12.4.1. Aud Specialty Pharmacies
12.4.2. General Specialty Pharmacies
13. Alcohol Use Disorder Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Alcohol Use Disorder Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Alcohol Use Disorder Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Alcohol Use Disorder Market
17. China Alcohol Use Disorder Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Alkermes plc
18.6. Aurobindo Pharma Ltd.
18.7. Cipla Limited
18.8. Dr. Reddy’s Laboratories Ltd.
18.9. H. Lundbeck A/S
18.10. Lupin Limited
18.11. Sandoz International GmbH
18.12. Sun Pharmaceutical Industries Ltd.
18.13. Teva Pharmaceutical Industries Ltd.
18.14. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ALCOHOL USE DISORDER MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ALCOHOL USE DISORDER MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ALCOHOL USE DISORDER MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ALCOHOL USE DISORDER MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISULFIRAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FAMILY THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FAMILY THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FAMILY THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOTIVATIONAL ENHANCEMENT THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CBT WITH PHARMACOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CBT WITH PHARMACOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CBT WITH PHARMACOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MET WITH PHARMACOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MET WITH PHARMACOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MET WITH PHARMACOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISPERSIBLE TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISPERSIBLE TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISPERSIBLE TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY EFFERVESCENT TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY IMMEDIATE RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY IMMEDIATE RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUSTAINED RELEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SUSTAINED RELEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME VISITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME VISITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOME VISITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TELEHEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY TELEHEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INPATIENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INPATIENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL REHABILITATION CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL REHABILITATION CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ALCOHOL REHABILITATION CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PSYCHIATRIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PSYCHIATRIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PSYCHIATRIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY E-COMMERCE WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY E-COMMERCE WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY E-COMMERCE WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOBILE APPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY MOBILE APPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY AUD SPECIALTY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY AUD SPECIALTY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY AUD SPECIALTY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY GENERAL SPECIALTY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY GENERAL SPECIALTY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY GENERAL SPECIALTY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL ALCOHOL USE DISORDER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2032 (USD MILLION)
TABLE 180. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 181. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 182. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 183. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 184. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 186. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 187. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2032 (USD MILLION)
TABLE 188. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 189. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 190. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 191. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 192. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 193. AMERICAS ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 199. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 200. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2032 (USD MILLION)
TABLE 201. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 202. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 203. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 204. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 205. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 207. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 208. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2032 (USD MILLION)
TABLE 209. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 210. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 212. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 213. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 214. NORTH AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 215. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 217. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2032 (USD MILLION)
TABLE 218. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2032 (USD MILLION)
TABLE 219. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 220. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 221. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2032 (USD MILLION)
TABLE 222. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 223. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 224. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 225. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 226. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 228. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 229. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2032 (USD MILLION)
TABLE 230. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 231. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 232. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 233. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 234. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 235. LATIN AMERICA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2032 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2032 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2032 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2032 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 257. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 258. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 259. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2032 (USD MILLION)
TABLE 260. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2032 (USD MILLION)
TABLE 261. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 262. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 263. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2032 (USD MILLION)
TABLE 264. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 265. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 266. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 267. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 268. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 270. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 271. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2032 (USD MILLION)
TABLE 272. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 273. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 274. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 275. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 276. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 277. EUROPE ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 278. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 279. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 280. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2032 (USD MILLION)
TABLE 281. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2032 (USD MILLION)
TABLE 282. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 283. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 284. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2032 (USD MILLION)
TABLE 285. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 286. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 287. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 288. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 289. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 291. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 292. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2032 (USD MILLION)
TABLE 293. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 294. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 295. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 296. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 297. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 298. MIDDLE EAST ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY PHARMACIES, 2018-2032 (USD MILLION)
TABLE 299. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 300. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 301. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY ACAMPROSATE, 2018-2032 (USD MILLION)
TABLE 302. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY NALTREXONE, 2018-2032 (USD MILLION)
TABLE 303. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 304. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY BEHAVIORAL THERAPY, 2018-2032 (USD MILLION)
TABLE 305. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY COMBINED THERAPY, 2018-2032 (USD MILLION)
TABLE 306. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY PHARMACOTHERAPY, 2018-2032 (USD MILLION)
TABLE 307. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 308. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 309. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY ORAL TABLET, 2018-2032 (USD MILLION)
TABLE 310. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 311. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY HOME HEALTHCARE, 2018-2032 (USD MILLION)
TABLE 312. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 313. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY REHABILITATION CENTERS, 2018-2032 (USD MILLION)
TABLE 314. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 315. AFRICA ALCOHOL USE DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD

Companies Mentioned

The key companies profiled in this Alcohol Use Disorder market report include:
  • Alkermes plc
  • Aurobindo Pharma Ltd.
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • H. Lundbeck A/S
  • Lupin Limited
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.46 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.17 Billion
Compound Annual Growth Rate6.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Medications for Alcohol Use Disorder Market - Global Forecast 2026-2032 - Product Image

Medications for Alcohol Use Disorder Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Alcohol Use Disorder Market Report and Forecast 2025-2034 - Product Image

Alcohol Use Disorder Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Alcohol Use Disorder - Pipeline Insight, 2025 - Product Image

Alcohol Use Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Alcohol Use Disorder Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Alcohol Use Disorder Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Alcoholism Treatment Market - Global Forecast 2026-2032 - Product Image

Alcoholism Treatment Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.